Skip to main content
. 2015 Oct 5;34(2):123–129. doi: 10.1200/JCO.2015.62.0138

Fig 3.

Fig 3.

Kaplan-Meier estimate of (A) overall (B) and intracranial progression-free survival from date of diagnosis of brain metastasis, stratified by treatment with tyrosine kinase inhibitor (TKI) before development of brain metastasis or initiation of TKI after diagnosis of brain metastasis.